can be used instead of potentially harmful adjuvants while still eliciting a thorough immune response, they are particularly interesting for vaccine development. Because synthetic peptides by themselves are insufficient to elicit an immune response, immunoadjuvants are frequently used to strengthen the reaction. In the development of peptide vaccines, alternatives to the traditional Freund's adjuvants have met with some success. These include conjugations to viral and bacterial carrier proteins, immunostimulating complexes, and branching multiple antigenic peptides (MAPS).

lipopeptides Myristic acid, palmitoyl, dipalmitoyl, geranyl, farnesyl, geranylgeranyl, and other lipids are only a few of the lipids that may be linked to nearly any peptide sequence by CPC due to its significant experience and knowledge in the synthesis of peptides containing lipid moieties.

Hopp, Thomas P. “Immunogenicity of a synthetic HBsAg peptide: enhancement by conjugation to a fatty acid carrier.” Molecular Immunology 21, no. 1 (1984): 13-16.

peptide manufacturing companies